Parents will be offered this sequencing at birth. They'll be offered tests for a set of 200 or more, perhaps conditions that have been agreed and decided beforehand are good to offer. This is a gold mine for researchers, isn't it? Well, it is for researches, but only if they're given access to the data,. That's not guaranteed. I think we need to think about what it might be like to have your own sequence available to use within a health system.
War and blockades in Ukraine are the largest but far from the only problems squeezing the global food system—and with prices already way up, a
catastrophe of hunger looms. The prospect of whole-genome screening for newborns opens up many opportunities to avoid or treat disease, and many
ethical debates. And more than just sordid history at Bangkok’s
red-light-district museum.For full access to print, digital and audio editions of
The Economist, subscribe here
www.economist.com/intelligenceoffer